Abstract
Long Evans rats were given atenolol doses ranging from 0.27 to 5.4 mg/kg by intraperitoneal injection. Animals were dosed once every 2 hr for a total of five doses. Atenolol concentrations 1 hr after the last dose were measured from simultaneously obtained plasma and cerebrospinal fluid (CSF) samples. CSF concentrations of atenolol were not proportional to plasma concentrations. The ratio of CSF/plasma concentrations was higher (0.33) at lower plasma atenolol levels (<100 ng/ml) than at the higher atenolol plasma levels (0.05) (P < 0.001). The relationship between plasma and cerebrospinal fluid atenolol concentrations was best described by the sum of a Michaelis–Menten and linear function. Animals were also given atenolol doses and then subjected to global cerebral ischemia. The relationship of atenolol concentrations from plasma and CSF in these animals was linear, with a constant partition ratio of 0.02. Together these data show that atenolol partitioning between plasma and CSF is nonlinear and possibly an energy-dependent process.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
P. B. Woods and M. L. Robinson. J. Pharm. Pharmacol. 33: 172–173 (1981).
J. M. Cruickshank, G. Neil-Dwyer, M. Cameron, and J. McAinish. Clin. Sci. 59:453S–455S (1980).
E. A. Taylor, D. Jefferson, J. D. Carrol, and P. Turner. Br. J. Clin. Pharmacol. 12:549–559 (1981).
G. Neil-Dwyer, J. Bartlett, J. McAinish, and J. M. Cruickshank. Br. J. Clin. Pharmacol. 11:549–553 (1981).
J. B. Kostis and R. C. Rosen. Circulation 75:204–212 (1987).
T. A. Betts and C. Alford. Eur. J. Clin. Pharmacol. 28 (Suppl.):65–68 (1985).
P. Van Gelder, M. Alpert, and W. H. Tsui. Eur. J. Clin. Pharmacol. 28 (Suppl.):101–103 (1985).
F. M. Gengo, L. Huntoon, and W. B. McHugh. Arch. Intern. Med. 147:39–43 (1987).
F. M. Gengo, S. C. Fagan, A. dePadova, J. K. Miller, and P. R. Kinkel. Arch. Intern. Med. (in press) (1988).
O. Lyngstam and L. Ryden. Acta Med. Scand. 209:261–266 (1981).
S. A. Salem and D. G. McDivitt. Clin. Pharmacol. Ther. 33:52–57 (1983).
D. N. Middlemis. Eur. J. Pharmacol. 120:51–56 (1986).
P. F. Morgan and T. W. Stone. Neurosci. Lett. 29:159–162 (1982).
W. M. Pardridge, R. Sakiyama, and G. Fierer. Am. J. Physiol. 247:R582–R588 (1984).
D. W. Schneck, J. F. Pritchard, and A. H. Hayes. J. Pharmacol. Exp. Ther. 203:621–629 (1977).
W. A. Pulsinelli and J. B. Brierley. Stroke 10:267–272 (1979).
F. M. Gengo, M. A. Ziemniak, W. R. Kinkel, and W. B. McHugh. J. Pharm. Sci. 73 (7):961–963 (1984).
B. Lemmer, K. Bathe, P. H. Lang, G. Neumann, and H. Winkler. J. Am. Coll. Toxicol. 2 (6):347–358 (1983).
L. Edvinsson. In F. Clifoford Rose (eds.), Advances in Headache Research, John Libbey & Co. Ltd., 1987.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gengo, F.M., Pagan, S.C., Hopkins, L.N. et al. Nonlinear Distribution of Atenolol Between Plasma and Cerebrospinal Fluid. Pharm Res 6, 248–251 (1989). https://doi.org/10.1023/A:1015973719096
Issue Date:
DOI: https://doi.org/10.1023/A:1015973719096